These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 18304679

  • 1. Non-alcoholic fatty liver disease: the mist gradually clears.
    de Alwis NM, Day CP.
    J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
    [Abstract] [Full Text] [Related]

  • 2. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [Abstract] [Full Text] [Related]

  • 3. Nonalcoholic fatty liver disease.
    Angulo P.
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [Abstract] [Full Text] [Related]

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 5. Pathology of nonalcoholic fatty liver disease.
    Yeh MM, Brunt EM.
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [Abstract] [Full Text] [Related]

  • 6. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC, Asia-Pacific Working Party on NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [Abstract] [Full Text] [Related]

  • 7. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.
    Targher G.
    Diabet Med; 2007 Jan; 24(1):1-6. PubMed ID: 17227317
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N.
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [Abstract] [Full Text] [Related]

  • 9. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G.
    Dig Dis; 2010 Nov; 28(1):210-3. PubMed ID: 20460913
    [Abstract] [Full Text] [Related]

  • 10. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG.
    Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G, Babini M.
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [Abstract] [Full Text] [Related]

  • 12. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, Rudilosso A, Ballestri S, Carulli N.
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [Abstract] [Full Text] [Related]

  • 13. Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease.
    Maislos M, Medvedovskv V, Sztarkier I, Yaari A, Sikuler E.
    Diabetes Res Clin Pract; 2006 Apr; 72(1):1-5. PubMed ID: 16242203
    [Abstract] [Full Text] [Related]

  • 14. Update on non-alcoholic fatty liver disease in children.
    Papandreou D, Rousso I, Mavromichalis I.
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [Abstract] [Full Text] [Related]

  • 15. Non-alcoholic fatty liver disease.
    Tuyama AC, Chang CY.
    J Diabetes; 2012 Sep; 4(3):266-80. PubMed ID: 22564417
    [Abstract] [Full Text] [Related]

  • 16. Nonalcoholic fatty liver disease.
    Adams LA, Lindor KD.
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [Abstract] [Full Text] [Related]

  • 17. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 18. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ.
    Diabetes Metab Res Rev; 2006 Jul; 22(6):437-43. PubMed ID: 16832839
    [Abstract] [Full Text] [Related]

  • 19. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM, McCullough AJ.
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [Abstract] [Full Text] [Related]

  • 20. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.